Clinical characterization, transmissibility, and seroconversion of SARS-CoV-2 infection in children (before the start of vaccination) in the Barcelona Metropolitan Region (Spain)

dc.contributor.author
Pons Tomàs, Gemma
dc.contributor.author
Hernández-García, M.
dc.contributor.author
Melé Casas, Maria
dc.contributor.author
de Sevilla, Mariona F.
dc.contributor.author
Launes Montaña, Cristian
dc.contributor.author
Girona Alarcón, Mònica
dc.contributor.author
Ríos Barnés, Maria
dc.contributor.author
Bassat Orellana, Quique
dc.contributor.author
Ajanovic, Sara
dc.contributor.author
Cubells, Marta
dc.contributor.author
Claverol, Joana
dc.contributor.author
Penela Sánchez, Daniel
dc.contributor.author
Jou, Cristina
dc.contributor.author
Monsonís, Manuel
dc.contributor.author
Esteva, Cristina
dc.contributor.author
Fassanella, Assumpta
dc.contributor.author
Cuadras, Daniel
dc.contributor.author
Muñoz-Almagro, Carmen
dc.contributor.author
Jordán García, Iolanda
dc.contributor.author
Fortuny Guasch, Claudia
dc.contributor.author
García García, Juan José
dc.contributor.author
Fumadó, Victoria
dc.date.issued
2026-01-13T09:36:14Z
dc.date.issued
2026-01-13T09:36:14Z
dc.date.issued
2024-07-22
dc.date.issued
2026-01-13T09:36:14Z
dc.identifier
1305-7707
dc.identifier
https://hdl.handle.net/2445/225353
dc.identifier
756331
dc.description.abstract
Objective: Analyzing the clinical and microbiological characteristics of coronavirus disease 2019 (COVID-19) infection in children seems essential to determine their role in the etiopathogenesis of the disease. Methods A prospective, longitudinal, and observational study, including children with severe acute respiratory syndrome coronavirus-2 infection, in the Barcelona Metropolitan Region (Spain), was performed. The recruitment pathways were: (1) children who attended a summer school and were included in an active surveillance study and (2) children who were visited in the Emergency Department of Hospital Sant Joan de Déu with symptoms. Close contacts with positive polymerase chain reaction (PCR) results were also included. The children recruited were followed up for 5 weeks. Evaluation of participants included a questionnaire for COVID-19 symptoms, nasopharyngeal swabbing for real-time PCR at 0, 7, and 14 days (weekly repeated up to week 5 if it resulted positive at 14 days), and serology testing at the recruitment and at the fifth week of follow-up. Results: A total of 90 children were recruited, of which 32% were asymptomatic. Transmission was studied in 70/90 children, and in 12 cases (17%), transmission to other children or adults was observed. No clinical or epidemiological differences were found between children who transmitted and those who did not. At the end of the follow-up, 11% of nasopharyngeal PCR remained positive. The serological response was studied in 73/90 children, and 80.82% of children seroconverted. Conclusion: No differences in epidemiological characteristics were found between children who transmitted and those who did not. PCR can be persistently positive for more than 5 weeks. The majority of patients who suffer from the disease produce antibodies against it.
dc.format
9 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Georg Thieme Verlag
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1055/s-0044-1787676
dc.relation
Journal of Pediatric Infectious Diseases, 2024, vol. 19, num.5, p. 251-259
dc.relation
https://doi.org/10.1055/s-0044-1787676
dc.rights
(c) Georg Thieme Verlag, 2024
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
COVID-19
dc.subject
Infeccions en els infants
dc.subject
COVID-19
dc.subject
Infection in children
dc.title
Clinical characterization, transmissibility, and seroconversion of SARS-CoV-2 infection in children (before the start of vaccination) in the Barcelona Metropolitan Region (Spain)
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)